China Archives - IMAA – Institute for Mergers, Acquisitions, and Alliances

Deal Capsule: Transactions In Chemicals & Pharmaceuticals July 2016

November 29, 2021August 5, 2016 by Christopher Kummer

by KPMG
The number of completed deals remained high in both sectors in HY1 2016. While total deal value for pharmaceuticals decreased, chemicals witnessed a 40% increase in HY1 2016 versus HY1 2015. Pharmaceutical M&A was impacted by stock market volatility, while new US regulatory rules struck down the $160 billion Pfizer-Allergan merger. Oncology and dermatology were key areas of interest for big pharma, who were especially keen on acquiring biotech assets. […] Read more

2016 Asian Trailblazers Study: Masters Of Multitasking And Transformation

September 13, 2022April 26, 2016 by Christopher Kummer

Figure 1. Asian Trailblazers are fine-tuning their strategy along several areas

by Willis Towers Watson
In 2012, an event occurred that went largely unnoticed. For the first time, the percentage of Asia Pacific-headquartered companies in the Fortune Global 500 outnumbered those headquartered in Europe and North America. That year, 36% of companies in the Fortune Global 500 were headquartered in Asia Pacific. Of these 181 organisations, 69 were headquartered in Mainland China and 68 in Japan. […] Read more

Global Capital Confidence Barometer – Buying And Bonding: Alliances Join M&A As Engines Of Growth

August 21, 2023April 23, 2016 by Christopher Kummer

by Ernst & Young
Our latest Global Capital Confidence Barometer continues to find a strong acquisition appetite together with a growing inclination to forge new alliances. Prolonged economic challenges are driving investment decisions, leading companies to ally and cooperate to generate growth as well as compete and acquire to gain market share. […] Read more

Deal Capsule: Transactions In Chemicals & Pharmaceuticals April 2016

August 21, 2023April 20, 2016 by Christopher Kummer

by KPMG
While the number of completed pharma deals were slightly higher in Q1 2016 versus Q1 2015, deal value was far lower in the absence of any >$10 billion completions. Only one deal exceeded $5 billion in Q1 2016 (versus 8 in Q1 2015). Specialization continues to be a driving force in Q1 2016, especially in sectors such as OTC, rare diseases and oncology. Declines in transaction values were also witnessed in chemicals. Downstream specialty chemicals was the leading focus area, notably in applications, resins and agrochemicals. […] Read more

Cross-Border Deals Tracker: Tracking Deal Flows Between Developed And Developing/Emerging Economies

November 29, 2021March 18, 2016 by Christopher Kummer

by KPMG
The latest deals data shows that the volume of developed market investments into emerging markets (D2E) hit a 10-year low over the second half of 2015, but emerging market deals with one another showed strong growth over the same period. Between July and December 2015, the number of D2E deals fell by 3 percent to 541, the lowest number in 10 years. The yearly total is also the lowest in 10 years, at 1101 D2E deals, 9 percent down on 2014. […] Read more

Insurance M&A Trends: A Year In Review And Predictions For 2016

August 21, 2023March 15, 2016 by Christopher Kummer

by KPMG
At the start of 2015, we made some predictions around how mergers and acquisitions (M&A) would impact the insurance sector. We did this in order to help clients plan their strategy in a rapidly evolving market. We anticipated a highly active year, centered on a number of key themes including consolidation, particularly within the property and casualty (P&C) segment and where industry fundamentals are affected by regulation, such as the US health care market. […] Read more

2016 Global Chemical Industry Mergers And Acquisitions Outlook: A Quest For Focus

November 29, 2021January 22, 2016 by Christopher Kummer

by Deloitte
In the Deloitte Touche Tohmatsu Limited (Deloitte Global) 2015 Global chemical industry mergers and acquisitions outlook, record levels of chemical mergers and acquisitions (M&A) activity in 2014 were observed, with a prediction that strong M&A momentum would continue in the industry into 2015. While the number of global chemical deals was relatively flat in 2015, the strong M&A momentum has continued with the number of global chemical deals in 2015 exceeding the previous six-year average by over 6 percent. […] Read more

How Emerging Markets Companies Can Avoid Growth Traps

November 29, 2021December 18, 2015 by Christopher Kummer

Exhibit 1 4 Phases of Capabilities Development

by Strategy&
Rapidly growing companies in the developing world can prepare themselves to do battle on a global stage by gaining access to vital capabilities through acquisitions or partnerships. It is extremely difficult for emerging market economies to sustain the rapid growth that stems from industrialization. […] Read more

Consumer Currents – Food For Thought: Do Grocers Need To Reinvent Their Business Model?

November 29, 2021December 17, 2015 by Christopher Kummer

by KPMG
As Albert Einstein shrewdly remarked: “If you always do what you always did, you will always get what you always got.” In the consumer marketplace in the 21st century we live in an age where innovation and reinvention is the key to growth. That is the challenge – and opportunity. […] Read more

Are you sure youwant to log out?

Are you sure you
want to log out?